NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline WLY Q1 2026 Earnings EPS Beats Estimates by 1167 IOBT Q3 2025 Earnings Narrower Loss Exceeds Expectations as Pipeline Execution Continues PRCT Q1 2026 Earnings NarrowerThanExpected Loss Reflects Operational Discipline PMTW Q1 2026 Earnings Significant EPS Miss as Trust Reports 016 vs 038 Estimate Neurocrine Biosciences NBIX Q1 2026 Earnings EPS Smashes Estimates Stock Edges Higher